Aristotle University Of Thessaloniki (AUTH)
Ανάπτυξη μεθόδων φαρμακοοικονομικής αξιολόγησης φαρμακευτικών αγωγών στα ασφαλιστικά συστήματα παροχών υγείας
Abstract
dc:descriptionSocial security Health Management Organizations (HMO’s) of the new era, challenged to meet the state budgetary limitations, are prone in seeking more efficient methods and decision making patterns, in order to rationalize the use of the sources available. The provision of the optimum therapeutic outcome to the insured patient is a dominant precondition according to the principles of the Evidence Based scientific practice. In other words the decision making process applied, predisposes the assessment and measurement of the expected outcomes and used sources and technologies, trying to optimise their balance. Pharmacoeconomics as a branch of Health Economics, with their scientific methodology are able to provide a valuable support to this task. The current study aimed to review the bibliography regarding pharmacoeconomics and its application as well as to perform comprehensive analysis of an entire pharmaceutical care system of a state in its individual framework. The methodological pattern development, necessary to the decision making in health care management issues was also pursuit. Romania was preferred to be the reference state to this analysis, consisting of an immature but developing market in rapid transition to the EU regulations. The Romanian pharmaceutical market was also providing a unique opportunity for comparisons annotations and development anticipations, given the capabilities and failures of the “mature” European systems of France, Spain and Greece revised and compared to it. The measurement of the pharmaceutical consumption was made by applying a cost minimization method together with a budget impact analysis. The model was preferred in order to better evaluate and prove the competences of the respective and practical regulatory interventions in health care and pharmacotherapy policies adopted in the country. The pharmaceutical consumption was analyzed during the decade 1996-2005 in 2005 to 2008 in order to reveal accurately the impact of the transient legislative and regulatory characteristics of Romania as compared to the other countries. A total of 927 active pharmaceutical ingredients (API’s) were registered, being contained in 3272 marketed products or 5824 pharmaceutical forms and formulations. The sum of the Defined Daily Dosages calculated in accordance to Αnatomic Therapeutic Classification system (ATC/DDD) that WHO adopts and yearly updates and the respective Daily Treatment Costs, together with the actual consumption in packages (units) sold and their readjusted values in USD exchange parity have been chosen as the most representative measures of the country consumption. A simulation of a methodological pattern for decision making with impact analysis was also applied based on the reclassification of APIs by homogeneous pharmacotherapy subgroups (easily subject to substitution) by selected/preferred therapeutic outcome.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vassilopoulos, Georgios
- Βασιλόπουλος, Γεώργιος
Subjects
dc:subject × 20- Φαρμακοοικονομία
- Φαρμακευτική δαπάνη
- Καθορισμένες ημερήσιες δόσεις
- Κόστος ημερήσιας θεραπείας
- Μέθοδος ελαχιστοποίησης κόστους
- Ανάλυση επίπτωσης στους προϋπολογισμούς
- Φαρμακολογική ταξινόμηση
- Επιλέξιμη θεραπευτική έκβαση
- Pharmacoeconomics
- Pharmaceutical expenditure
- Defined daily dosages
- Daily treatment cost
- Cost minimization method
- Budget impact analysis
- Pharmacology clustering
- Selected therapeutic outcome
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23307